HLA-C and MHC class II deficiency: A fourth RFX gene (RFX4) was discovered in a human breast tumor tissue [8] and the fifth, RFX5, was identified as a DNA-binding regulatory factor that is mutated in primary MHC class II deficiency (bare lymphocyte syndrome, BLS) [9].